nodes	percent_of_prediction	percent_of_DWPC	metapath
Cycloserine—DDC—telencephalic ventricle—Alzheimer's disease	0.0721	0.458	CbGeAlD
Cycloserine—SLC36A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC24A4—Alzheimer's disease	0.035	0.09	CbGpPWpGaD
Cycloserine—Paresis—Rivastigmine—Alzheimer's disease	0.031	0.0684	CcSEcCtD
Cycloserine—Drug hypersensitivity—Memantine—Alzheimer's disease	0.0287	0.0633	CcSEcCtD
Cycloserine—Hyperreflexia—Rivastigmine—Alzheimer's disease	0.0245	0.054	CcSEcCtD
Cycloserine—DDC—Dopamine metabolism—MAOB—Alzheimer's disease	0.0219	0.0562	CbGpPWpGaD
Cycloserine—DDC—embryo—Alzheimer's disease	0.0213	0.135	CbGeAlD
Cycloserine—DDC—Biogenic Amine Synthesis—CHAT—Alzheimer's disease	0.0203	0.0523	CbGpPWpGaD
Cycloserine—DDC—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.02	0.0514	CbGpPWpGaD
Cycloserine—DDC—Nicotine Activity on Dopaminergic Neurons—CDK5—Alzheimer's disease	0.0197	0.0505	CbGpPWpGaD
Cycloserine—DDC—forebrain—Alzheimer's disease	0.0188	0.12	CbGeAlD
Cycloserine—Aggression—Galantamine—Alzheimer's disease	0.0187	0.0413	CcSEcCtD
Cycloserine—DDC—telencephalon—Alzheimer's disease	0.0173	0.11	CbGeAlD
Cycloserine—DDC—Biogenic Amine Synthesis—ACHE—Alzheimer's disease	0.0158	0.0405	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC24A4—Alzheimer's disease	0.0157	0.0402	CbGpPWpGaD
Cycloserine—Aggression—Donepezil—Alzheimer's disease	0.0145	0.032	CcSEcCtD
Cycloserine—DDC—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.0139	0.0356	CbGpPWpGaD
Cycloserine—Dysarthria—Donepezil—Alzheimer's disease	0.0135	0.0297	CcSEcCtD
Cycloserine—DDC—Parkinsons Disease Pathway—LRRK2—Alzheimer's disease	0.0134	0.0344	CbGpPWpGaD
Cycloserine—Aggression—Memantine—Alzheimer's disease	0.0132	0.029	CcSEcCtD
Cycloserine—DDC—Nicotine Activity on Dopaminergic Neurons—CHRNB2—Alzheimer's disease	0.0131	0.0337	CbGpPWpGaD
Cycloserine—Aggression—Rivastigmine—Alzheimer's disease	0.0129	0.0284	CcSEcCtD
Cycloserine—DDC—Dopamine metabolism—SOD1—Alzheimer's disease	0.0126	0.0323	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—SNCA—Alzheimer's disease	0.012	0.0308	CbGpPWpGaD
Cycloserine—Dysarthria—Rivastigmine—Alzheimer's disease	0.012	0.0264	CcSEcCtD
Cycloserine—DDC—Nicotine Activity on Dopaminergic Neurons—CHRNA4—Alzheimer's disease	0.0119	0.0306	CbGpPWpGaD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—SLC30A6—Alzheimer's disease	0.0109	0.0279	CbGpPWpGaD
Cycloserine—Coma—Memantine—Alzheimer's disease	0.0106	0.0233	CcSEcCtD
Cycloserine—Coma—Rivastigmine—Alzheimer's disease	0.0103	0.0228	CcSEcCtD
Cycloserine—DDC—nervous system—Alzheimer's disease	0.0102	0.0649	CbGeAlD
Cycloserine—Cardiac failure congestive—Donepezil—Alzheimer's disease	0.0102	0.0225	CcSEcCtD
Cycloserine—DDC—central nervous system—Alzheimer's disease	0.00983	0.0625	CbGeAlD
Cycloserine—Disorientation—Memantine—Alzheimer's disease	0.00938	0.0207	CcSEcCtD
Cycloserine—Cardiac failure congestive—Memantine—Alzheimer's disease	0.00926	0.0204	CcSEcCtD
Cycloserine—Osteoarthritis—Donepezil—Alzheimer's disease	0.00925	0.0204	CcSEcCtD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—APOD—Alzheimer's disease	0.00923	0.0237	CbGpPWpGaD
Cycloserine—Psychotic disorder—Donepezil—Alzheimer's disease	0.00903	0.0199	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.00893	0.0229	CbGpPWpGaD
Cycloserine—Osteoarthritis—Memantine—Alzheimer's disease	0.00839	0.0185	CcSEcCtD
Cycloserine—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.00821	0.0181	CcSEcCtD
Cycloserine—Psychotic disorder—Memantine—Alzheimer's disease	0.0082	0.0181	CcSEcCtD
Cycloserine—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.00802	0.0177	CcSEcCtD
Cycloserine—DDC—Tryptophan metabolism—MAOB—Alzheimer's disease	0.00796	0.0204	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.00796	0.0204	CbGpPWpGaD
Cycloserine—DDC—brain—Alzheimer's disease	0.00781	0.0496	CbGeAlD
Cycloserine—Tremor—Galantamine—Alzheimer's disease	0.00673	0.0148	CcSEcCtD
Cycloserine—Vertigo—Galantamine—Alzheimer's disease	0.00645	0.0142	CcSEcCtD
Cycloserine—Drowsiness—Rivastigmine—Alzheimer's disease	0.00633	0.014	CcSEcCtD
Cycloserine—Convulsion—Galantamine—Alzheimer's disease	0.00622	0.0137	CcSEcCtD
Cycloserine—Confusional state—Galantamine—Alzheimer's disease	0.00591	0.013	CcSEcCtD
Cycloserine—SLC36A2—SLC-mediated transmembrane transport—CP—Alzheimer's disease	0.00579	0.0149	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.00551	0.0142	CbGpPWpGaD
Cycloserine—Paraesthesia—Galantamine—Alzheimer's disease	0.00526	0.0116	CcSEcCtD
Cycloserine—Tremor—Donepezil—Alzheimer's disease	0.00522	0.0115	CcSEcCtD
Cycloserine—Somnolence—Galantamine—Alzheimer's disease	0.00521	0.0115	CcSEcCtD
Cycloserine—Vertigo—Donepezil—Alzheimer's disease	0.005	0.011	CcSEcCtD
Cycloserine—Feeling abnormal—Galantamine—Alzheimer's disease	0.00483	0.0107	CcSEcCtD
Cycloserine—Convulsion—Donepezil—Alzheimer's disease	0.00482	0.0106	CcSEcCtD
Cycloserine—Tremor—Memantine—Alzheimer's disease	0.00474	0.0104	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.00469	0.012	CbGpPWpGaD
Cycloserine—Tremor—Rivastigmine—Alzheimer's disease	0.00463	0.0102	CcSEcCtD
Cycloserine—Confusional state—Donepezil—Alzheimer's disease	0.00458	0.0101	CcSEcCtD
Cycloserine—Vertigo—Memantine—Alzheimer's disease	0.00454	0.01	CcSEcCtD
Cycloserine—DDC—Amino acid and derivative metabolism—HSD17B10—Alzheimer's disease	0.00449	0.0115	CbGpPWpGaD
Cycloserine—Vertigo—Rivastigmine—Alzheimer's disease	0.00444	0.0098	CcSEcCtD
Cycloserine—Convulsion—Memantine—Alzheimer's disease	0.00438	0.00966	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.00432	0.0111	CbGpPWpGaD
Cycloserine—Hypersensitivity—Galantamine—Alzheimer's disease	0.00432	0.00953	CcSEcCtD
Cycloserine—Convulsion—Rivastigmine—Alzheimer's disease	0.00428	0.00945	CcSEcCtD
Cycloserine—Confusional state—Memantine—Alzheimer's disease	0.00416	0.00918	CcSEcCtD
Cycloserine—Paraesthesia—Donepezil—Alzheimer's disease	0.00408	0.009	CcSEcCtD
Cycloserine—Confusional state—Rivastigmine—Alzheimer's disease	0.00407	0.00898	CcSEcCtD
Cycloserine—Somnolence—Donepezil—Alzheimer's disease	0.00404	0.00891	CcSEcCtD
Cycloserine—Feeling abnormal—Donepezil—Alzheimer's disease	0.00374	0.00826	CcSEcCtD
Cycloserine—Paraesthesia—Memantine—Alzheimer's disease	0.0037	0.00817	CcSEcCtD
Cycloserine—Rash—Galantamine—Alzheimer's disease	0.0037	0.00815	CcSEcCtD
Cycloserine—Dermatitis—Galantamine—Alzheimer's disease	0.00369	0.00815	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.00368	0.00944	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.00368	0.00944	CbGpPWpGaD
Cycloserine—Headache—Galantamine—Alzheimer's disease	0.00367	0.0081	CcSEcCtD
Cycloserine—Somnolence—Memantine—Alzheimer's disease	0.00367	0.00809	CcSEcCtD
Cycloserine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00362	0.00799	CcSEcCtD
Cycloserine—Somnolence—Rivastigmine—Alzheimer's disease	0.00359	0.00791	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.00356	0.00915	CbGpPWpGaD
Cycloserine—Feeling abnormal—Memantine—Alzheimer's disease	0.0034	0.0075	CcSEcCtD
Cycloserine—Hypersensitivity—Donepezil—Alzheimer's disease	0.00335	0.00738	CcSEcCtD
Cycloserine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00333	0.00734	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.00313	0.00803	CbGpPWpGaD
Cycloserine—Hypersensitivity—Memantine—Alzheimer's disease	0.00304	0.0067	CcSEcCtD
Cycloserine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00297	0.00656	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.00294	0.00756	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.00294	0.00755	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.00288	0.00741	CbGpPWpGaD
Cycloserine—Rash—Donepezil—Alzheimer's disease	0.00287	0.00632	CcSEcCtD
Cycloserine—Dermatitis—Donepezil—Alzheimer's disease	0.00286	0.00631	CcSEcCtD
Cycloserine—Headache—Donepezil—Alzheimer's disease	0.00285	0.00628	CcSEcCtD
Cycloserine—DDC—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.00264	0.00678	CbGpPWpGaD
Cycloserine—Rash—Memantine—Alzheimer's disease	0.0026	0.00574	CcSEcCtD
Cycloserine—Dermatitis—Memantine—Alzheimer's disease	0.0026	0.00573	CcSEcCtD
Cycloserine—Headache—Memantine—Alzheimer's disease	0.00258	0.0057	CcSEcCtD
Cycloserine—Rash—Rivastigmine—Alzheimer's disease	0.00254	0.00561	CcSEcCtD
Cycloserine—Dermatitis—Rivastigmine—Alzheimer's disease	0.00254	0.00561	CcSEcCtD
Cycloserine—Headache—Rivastigmine—Alzheimer's disease	0.00253	0.00558	CcSEcCtD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.0025	0.00643	CbGpPWpGaD
Cycloserine—DDC—Parkinsons Disease Pathway—CASP3—Alzheimer's disease	0.0025	0.00642	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.0024	0.00615	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.00237	0.00608	CbGpPWpGaD
Cycloserine—DDC—Dopaminergic Neurogenesis—TGFB1—Alzheimer's disease	0.00235	0.00604	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.00223	0.00572	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.00217	0.00557	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.00217	0.00557	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—CST3—Alzheimer's disease	0.00215	0.00553	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—CHRNB2—Alzheimer's disease	0.00215	0.00553	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—CRH—Alzheimer's disease	0.00196	0.00502	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—NPS—Alzheimer's disease	0.00185	0.00476	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—SLC6A4—Alzheimer's disease	0.00182	0.00467	CbGpPWpGaD
Cycloserine—SLC36A2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.00175	0.0045	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.00166	0.00428	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.00162	0.00415	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.00155	0.00399	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—NGFR—Alzheimer's disease	0.00152	0.0039	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.0015	0.00386	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.00144	0.00369	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.00137	0.00351	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—PPARGC1A—Alzheimer's disease	0.00136	0.00349	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—PRKCG—Alzheimer's disease	0.0012	0.00309	CbGpPWpGaD
Cycloserine—DDC—Metabolism—DHCR24—Alzheimer's disease	0.00119	0.00306	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.00109	0.0028	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—LEP—Alzheimer's disease	0.00104	0.00266	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CA4—Alzheimer's disease	0.00101	0.0026	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—NOS2—Alzheimer's disease	0.000966	0.00248	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GAPDHS—Alzheimer's disease	0.000952	0.00244	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—PPARG—Alzheimer's disease	0.000903	0.00232	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ATP5A1—Alzheimer's disease	0.000902	0.00232	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—GSK3B—Alzheimer's disease	0.000898	0.00231	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—CREB1—Alzheimer's disease	0.000891	0.00229	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PLD3—Alzheimer's disease	0.000861	0.00221	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HSD17B10—Alzheimer's disease	0.000825	0.00212	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.00081	0.00208	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.000808	0.00208	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CYP46A1—Alzheimer's disease	0.000794	0.00204	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ND1—Alzheimer's disease	0.000767	0.00197	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.000686	0.00176	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—MAPK8—Alzheimer's disease	0.000606	0.00156	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.000588	0.00151	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CHAT—Alzheimer's disease	0.000494	0.00127	CbGpPWpGaD
Cycloserine—DDC—Metabolism—TPI1—Alzheimer's disease	0.000494	0.00127	CbGpPWpGaD
Cycloserine—DDC—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.000474	0.00122	CbGpPWpGaD
Cycloserine—DDC—Metabolism—MAOB—Alzheimer's disease	0.000474	0.00122	CbGpPWpGaD
Cycloserine—DDC—Metabolism—GAPDH—Alzheimer's disease	0.000456	0.00117	CbGpPWpGaD
Cycloserine—DDC—Metabolism—A2M—Alzheimer's disease	0.000441	0.00113	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—TP53—Alzheimer's disease	0.000423	0.00109	CbGpPWpGaD
Cycloserine—DDC—Circadian rythm related genes—IL6—Alzheimer's disease	0.000387	0.000994	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ACHE—Alzheimer's disease	0.000383	0.000985	CbGpPWpGaD
Cycloserine—DDC—Metabolism—INPP5D—Alzheimer's disease	0.000379	0.000973	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ENO1—Alzheimer's disease	0.000359	0.000923	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PTGS1—Alzheimer's disease	0.000359	0.000923	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CYP2D6—Alzheimer's disease	0.000352	0.000905	CbGpPWpGaD
Cycloserine—DDC—Metabolism—BCHE—Alzheimer's disease	0.000334	0.000858	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PLCB1—Alzheimer's disease	0.000315	0.000809	CbGpPWpGaD
Cycloserine—DDC—Metabolism—ABCA1—Alzheimer's disease	0.000305	0.000785	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PPARGC1A—Alzheimer's disease	0.000263	0.000676	CbGpPWpGaD
Cycloserine—DDC—Metabolism—HMOX1—Alzheimer's disease	0.000262	0.000673	CbGpPWpGaD
Cycloserine—DDC—Metabolism—LPL—Alzheimer's disease	0.00024	0.000616	CbGpPWpGaD
Cycloserine—DDC—Metabolism—MTHFR—Alzheimer's disease	0.000216	0.000554	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CALM1—Alzheimer's disease	0.000202	0.000518	CbGpPWpGaD
Cycloserine—DDC—Metabolism—APOE—Alzheimer's disease	0.000201	0.000516	CbGpPWpGaD
Cycloserine—DDC—Metabolism—CAV1—Alzheimer's disease	0.000199	0.000511	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PPARG—Alzheimer's disease	0.000175	0.000449	CbGpPWpGaD
Cycloserine—DDC—Metabolism—INS—Alzheimer's disease	0.000172	0.000441	CbGpPWpGaD
Cycloserine—DDC—Metabolism—NOS3—Alzheimer's disease	0.00015	0.000387	CbGpPWpGaD
Cycloserine—DDC—Metabolism—PTGS2—Alzheimer's disease	0.000138	0.000354	CbGpPWpGaD
Cycloserine—DDC—Metabolism—AKT1—Alzheimer's disease	6.92e-05	0.000178	CbGpPWpGaD
